What is the recommended management for extensive onychomycosis?

Management of Extensive Onychomycosis

For extensive onychomycosis, oral terbinafine 250 mg daily for 12-16 weeks (toenails) or 6 weeks (fingernails) is the first-line treatment and should be strongly preferred over other systemic options due to superior efficacy, lower relapse rates, and minimal drug interactions. 1

Treatment Algorithm for Extensive Disease

First-Line: Oral Terbinafine

• Dosing: 250 mg daily for 12-16 weeks for toenails; 6 weeks for fingernails 1
• Efficacy: Achieves 55% complete cure at 72 weeks with only 23% mycological relapse and 21% clinical relapse at 5 years 1
• Pre-treatment monitoring: Baseline liver function tests and complete blood count in patients with history of heavy alcohol use, hepatitis, or hematological abnormalities 1
• Re-evaluation: Assess at 3-6 months after treatment initiation; provide additional treatment if disease persists 1

The evidence strongly favors terbinafine over alternatives. A multicentre randomized trial of 508 subjects demonstrated terbinafine achieved 55% complete cure versus only 26% with pulsed itraconazole at 72 weeks, with significantly lower long-term relapse rates (23% vs 53% mycological relapse) 1.

Second-Line: Oral Itraconazole

Use when terbinafine is contraindicated (active liver disease, renal impairment) or not tolerated 1:

• Continuous regimen: 200 mg daily for 12 weeks 1
• Pulse regimen: 400 mg daily for 1 week per month (2 pulses for fingernails, 3 pulses for toenails) 1
• Contraindications: Heart failure, hepatotoxicity 1
• Monitoring: Hepatic function tests in patients with pre-existing abnormalities, those on continuous therapy >1 month, or with concomitant hepatotoxic drugs 1
• Administration: Take with food and acidic pH for optimal absorption 1

Third-Line: Oral Fluconazole

Reserve for patients unable to tolerate terbinafine or itraconazole 1:

• Dosing: 150-450 mg weekly for ≥6 months (toenails) or 3 months (fingernails) 1
• Efficacy: Lower than terbinafine/itraconazole (47-62% mycological cure for toenails) but once-weekly dosing improves compliance 1
• Caution: Higher doses (300-450 mg) associated with 58% treatment discontinuation rate 1

Combination Therapy for Extensive Disease

Strongly consider adding topical therapy to oral treatment for extensive onychomycosis to increase cure rates and reduce fungal load 1:

Topical Options (as adjuncts):

• Amorolfine 5% lacquer: Once or twice weekly for 6-12 months 1
• Ciclopirox 8% lacquer: Daily for up to 48 weeks 1

Combination therapy exploits complementary mechanisms of action and drug penetration to different nail unit parts, potentially yielding better outcomes than monotherapy 2.

Critical Management Points

Nail Debridement

Always perform mechanical debridement of infected keratin as the first step - this reduces fungal load and enhances drug penetration 3. Keep nails as short as possible throughout treatment 1.

Common Pitfalls to Avoid:

1. Taste disturbance with terbinafine: Warn patients this can be permanent, though very rare 1
2. Drug interactions with itraconazole: Extensive cytochrome P450 interactions; review medication list carefully 1
3. Hepatotoxicity: Do not use terbinafine in active/chronic liver disease 1
4. Premature treatment cessation: Terbinafine persists in nails for 6 months post-treatment; clinical improvement continues after stopping medication 1

Preventing Recurrence

Implement these measures to address the 25-50% recurrence rate 2:

• Always wear protective footwear in public bathing facilities, gyms, hotel rooms 1
• Apply antifungal powders (miconazole, clotrimazole, tolnaftate) in shoes and on feet 1
• Wear cotton, absorbent socks 1
• Discard old footwear or treat with naphthalene mothballs in sealed plastic bags for ≥3 days 1
• Treat concurrent tinea pedis and all infected family members simultaneously 1

When to Consider Specialist Referral:

• Treatment failure after appropriate first-line therapy 4
• Presence of dermatophytoma or nail matrix involvement 4
• Multiple comorbidities (immunocompromised, diabetes) 4
• Involvement of all nails 4

The British Association of Dermatologists guidelines provide Grade A recommendations for both terbinafine and itraconazole as first-line treatments, but explicitly state terbinafine should be "generally preferred" based on superior efficacy and tolerability 1.